NCT02753335

Brief Summary

The intention of this trial is to investigate whether combined Graded Motor Imagery (GMI) and Desensitization (D) among patients with CRPS is clinically more effective than only D and to study changes in connectivity in the Default Mode Network before and after treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 27, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2016

Completed
7.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

May 11, 2023

Status Verified

May 1, 2023

Enrollment Period

7.3 years

First QC Date

March 3, 2016

Last Update Submit

May 10, 2023

Conditions

Keywords

CRPS, graded motor imagery, desensitization, fMRI, DMN

Outcome Measures

Primary Outcomes (2)

  • Group difference in pain intensity

    Continuous numeric variable using a visual analog scale from minimum 0 to maximum 100

    6 weeks after baseline

  • Change from baseline in intra-network connectivity in the Default Mode Network

    Continuous variable

    6 months after baseline

Secondary Outcomes (15)

  • Change from baseline in pain intensity

    6 weeks after baseline

  • Change from baseline in pain intensity

    6 months after baseline

  • Change from baseline in pain intensity

    12 months after baseline

  • Group difference in CRPS Severity Score

    6 weeks after baseline

  • Change from baseline in CRPS Severity Score

    6 weeks after baseline

  • +10 more secondary outcomes

Study Arms (2)

GMI and Desensitization

EXPERIMENTAL

Left/right judgement, imagine movements of the affected area, mirror treatment and tactile stimulation of the affected limb with different materials.

Behavioral: GMI and Desensitization

Desensitization

EXPERIMENTAL

Tactile stimulation of the affected limb with different materials.

Behavioral: Desensitization

Interventions

Graded Motor Imagery (GMI) is used to treat chronic pain conditions and movement problems related to alterations in the nervous system such as CRPS, postamputation limb pain and back pain. The patient is trained in monitored steps. The three treatment components include left/right discrimination training, motor imagery exercises and mirror observations of the unaffected limb, appearing as the affected limb. They are performed sequentially, but require a flexible approach to suit the individual patient. The imagined movements have been demonstrated to activate motor cortical areas similar to those activated in the actual execution of that movement. Desensitization (D) is used to decrease hyperalgesia by repeated tactile stimulation of the affected area with various materials.

GMI and Desensitization
DesensitizationBEHAVIORAL

Desensitization (D) is used to decrease hyperalgesia and allodynia by repeated tactile stimulation of the affected area with various materials.

Desensitization

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 - 70 years old. For patients who only participate in the clinical RCT (without fMRI) no upper age limit.
  • CRPS affecting one single upper or lower limb diagnosed by the IASP (2012) Budapest research criteria (Harden et al., 2010).
  • Triggering trauma or the onset of pain \>3 months ago.
  • If possible drugs that can influence the fMRI scans should be avoided. Documentation if used.

You may not qualify if:

  • Drug abuse.
  • Malignant/progressive, systemic or neurodegenerative disease.
  • Other severe pain conditions.
  • Severe clinical anxiety or depression, symptoms of fatigue or ME of a disabling level.
  • For patients who participate in the MRI related analyses:
  • Metallic implants incompatible with the MR technology or medical condition not recommended for fMRI.
  • Pregnancy.
  • Phobia for MRI examination.
  • Diseases that can cause structural changes and interfere with the interpretation of the MRI-scans (like severe diabetes mellitus, heart disease, ischemic stroke and vascular conditions).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of North Norway

Tromsø, 9038, Norway

RECRUITING

Related Publications (1)

  • Smart KM, Ferraro MC, Wand BM, O'Connell NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II. Cochrane Database Syst Rev. 2022 May 17;5(5):CD010853. doi: 10.1002/14651858.CD010853.pub3.

MeSH Terms

Conditions

Complex Regional Pain Syndromes

Interventions

Desensitization, Psychologic

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesPeripheral Nervous System DiseasesNeuromuscular Diseases

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Gunnvald Kvarstein, PhD

    University of Tromso

    STUDY CHAIR

Central Study Contacts

Gunnvald Kvarstein, PhD

CONTACT

Danielsson Lena, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2016

First Posted

April 27, 2016

Study Start

September 1, 2016

Primary Completion

December 1, 2023

Study Completion

December 1, 2024

Last Updated

May 11, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations